🚨 Call for Papers – Special Collection! @tamedoncol.bsky.social seeks submissions on: De-escalation of Treatment in Gynecologic Cancers. 🗓️ Submit by March 18, 2026 📥 Submit:
10.10.2025 07:15 — 👍 2 🔁 2 💬 0 📌 0
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
Systematic review/meta-analysis (2013–2024, n=23,319): In febrile neutropenia after chemotherapy, bloodstream infections were 59% Gram-negative, 39.7% Gram-positive, and 2.5% fungal.
journals.sagepub.com/doi/full/10....
10.10.2025 12:41 — 👍 2 🔁 2 💬 0 📌 0
In patients with metastatic #gastriccancer, earlier nivolumab monotherapy infusions (before 14:00) were associated with significantly longer PFS and OS (7.6 vs 3.9 mo). Authors suggest infusion timing may influence outcomes in #Immunotherapy practice.
🔗 journals.sagepub.com/doi/epdf/10....
10.10.2025 15:48 — 👍 1 🔁 1 💬 0 📌 0
In HER2-mutated non-small-cell lung cancer, combination regimens achieved markedly better outcomes than single-agent approaches.
Median PFS: 7.8 vs 5.3 mo; best results seen with chemo + immunotherapy + anti-angiogenic therapy.
🔗 journals.sagepub.com/doi/epdf/10....
10.10.2025 15:51 — 👍 2 🔁 1 💬 0 📌 0
In HER2+ salivary duct carcinoma, trastuzumab-deruxtecan (T-Dxd) achieved 13 months of disease control in a multitreated 44-year-old patient, supporting further study of anti-HER2 therapy in rare salivary tumors.
🔗 journals.sagepub.com/doi/epdf/10....
#HER2 #SalivaryCancer #Oncology
10.10.2025 15:54 — 👍 1 🔁 1 💬 0 📌 0
In HR+ advanced #BreastCancer progressing after CDK4/6 inhibitors, network meta-analysis (19 RCTs; n=6621) found CDK4/6i + fulvestrant most effective for PFS, especially in visceral metastases or ESR1 mutations; Bcl-2i + Ful and SERDs also showed benefit
journals.sagepub.com/doi/epdf/10....
10.10.2025 15:57 — 👍 1 🔁 1 💬 0 📌 0
In non-metastatic HER2− #BreastCancer, NCDB data (2018) showed higher pCR rates with neoadjuvant chemo in HR-Low vs HR-High groups. HR-Low tumors had higher grade/stage and lower endocrine therapy use, underscoring need for clearer treatment guidance.
🔗 journals.sagepub.com/doi/epdf/10....
10.10.2025 15:59 — 👍 1 🔁 1 💬 0 📌 0
In #ParkinsonsDisease, orthostatic hypotension (OH) is a disabling feature linked to poor quality of life and fall risk. This review summarizes pharmacologic and nonpharmacologic strategies for managing OH in PD.
🔗 journals.sagepub.com/doi/epdf/10....
10.10.2025 16:08 — 👍 1 🔁 1 💬 0 📌 0
In rescue stenting after failed thrombectomy, dual antiplatelet therapy post-procedure improved outcomes and reduced mortality and stent occlusion vs single therapy. Most occlusions occurred within 24 h, underscoring early management importance.
🔗 journals.sagepub.com/doi/epdf/10....
10.10.2025 16:09 — 👍 1 🔁 1 💬 0 📌 0
In #ALS, analysis of 636 patients (2013–2023) found racial and ethnic disparities in care: Non-Hispanic Black patients had higher tracheostomy rates, and Hispanic patients were less likely to receive riluzole. Survival was similar across groups.
🔗 journals.sagepub.com/doi/epdf/10....
10.10.2025 16:11 — 👍 1 🔁 1 💬 0 📌 0
🧬 Article collection on @tamedoncol.bsky.social: PARPi in Gynecologic Cancers. This collection highlights research on HRR genetic landscape, PARPi outcomes, oxaliplatin sequencing in BRCA-mutated ovarian cancer, and PARPi resistance with combination strategies. 📚 Explore more
07.10.2025 07:15 — 👍 1 🔁 1 💬 0 📌 0
Zolbetuximab is gaining attention as a targeted therapy for CLDN18.2-positive gastric and GEJ cancers.
This review dives into the science behind Claudin18.2 and the clinical promise of zolbetuximab, backed by SPOTLIGHT and GLOW trial data.
buff.ly/ok6eO7y
#Oncology #GastricCancer #Zolbetuximab
08.10.2025 07:15 — 👍 1 🔁 1 💬 0 📌 0
BRCA1/2-mutant early #BreastCancer: review urges region-tailored testing in Latin America, MRI-first screening, and shared surgical decision making. Neo-adjuvant platinum can raise pCR, while adjuvant olaparib improves OS. #BRCA #TNBC #PARPi #Latam
06.10.2025 16:54 — 👍 2 🔁 1 💬 0 📌 0
Lung cancer is varying by region in risks and traits. A new article examines carcinogens, genetic predisposition, and molecular epidemiology. We seek submissions on geographic differences in lung cancer. Deadline: Dec 31, 2025 🔗 buff.ly/JCo9lJP #CancerResearch #LungCancer #GlobalHealth
05.10.2025 07:15 — 👍 1 🔁 1 💬 0 📌 0
Real-world analysis of HER2-ultralow in HR+/HER2– metastatic breast cancer: prevalence and first-line chemotherapy outcomes
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cancertreatment #precisiononcology #ADCtherapy #oncology
03.10.2025 21:52 — 👍 1 🔁 0 💬 0 📌 0
Design of an artificial natural killer cell mimicking system to target tumour cells
Journal of Tissue Engineering
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#immunotherapy #nanomedicine #NKcells #targeteddrugdelivery #openaccess
03.10.2025 21:49 — 👍 1 🔁 0 💬 0 📌 0
Is Site of Radiation Therapy Associated With Pathologic Complete Response in Patients With Locally Advanced Esophageal Cancer?
@cancer-control.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#radiationoncology #radiotherapy #cancercare #cancertreatment #openaccess
03.10.2025 21:47 — 👍 2 🔁 1 💬 0 📌 0
Identification of Potent HDAC6 Inhibitors for Breast Cancer Through Multi-Stage In Silico Modeling
Bioinformatics and Biology Insights
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cancerresearch #precisiononcology #drugdiscovery #openaccess
03.10.2025 21:45 — 👍 0 🔁 0 💬 0 📌 0
Cardioprotective effectiveness of SGLT2 inhibitors in older diabetic women with early-stage breast cancer following anthracycline- and/or trastuzumab-based treatment
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cardiooncology
03.10.2025 21:44 — 👍 0 🔁 0 💬 0 📌 0
Understanding the Impact of Individual Nucleotide on Oxford Nanopore Current Signals With Interpretable Prediction Models
Bioinformatics and Biology Insights
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#nanoporesequencing #bioinformatics #DNAsequencing #MachineLearning #openaccess
03.10.2025 21:41 — 👍 3 🔁 1 💬 0 📌 1
A patient-specific engineered tissue model of BAG3-mediated cardiomyopathy
Journal of Tissue Engineering
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cardiactissueengineering #dilatedcardiomyopathy #iPSCmodels #precisioncardiology #openaccess
03.10.2025 21:39 — 👍 0 🔁 0 💬 0 📌 0
Early and hereditary breast cancer: advances in risk stratification and imaging approaches
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#precisiononcology #radiomics #hereditarycancer #IAIinHealthcare #openaccess
03.10.2025 21:37 — 👍 1 🔁 0 💬 0 📌 0
The CHD Protein, Kismet, Restricts Synaptic BMP Signaling at Glutamatergic Synapses
Neuroscience Insights
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#chromatinremodeling #synapticplasticity #neurodevelpmentaldisorders #openaccess
03.10.2025 21:33 — 👍 1 🔁 0 💬 0 📌 0
New article shows Claudin 18.2 expression does not impact immunotherapy outcomes in Advanced Gastric Cancer treatment
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cancertreatment #oncology #immunotherapy #chemotherapy #openaccess
03.10.2025 21:31 — 👍 0 🔁 0 💬 0 📌 0
A Preliminary Prospective Study on the Association of Polymorphisms in BDNF, ARRB2 and KCNJ6 and Response to Fentanyl for Pain Management in Advanced Cancer
@cancer-control.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cancercare #dosingguidelines #pharmacogenomics
03.10.2025 21:27 — 👍 1 🔁 1 💬 0 📌 0
Effect of dapagliflozin on proteinuria and the slope of the estimated glomerular filtration rate in patients with immunoglobulin A nephropathy: A multicenter prospective study
Journal of International Medical Research
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#kidneyresearch
03.10.2025 21:24 — 👍 0 🔁 0 💬 0 📌 0
🦠 Phytochemicals in the Transmission Control of Epidemic Viruses: A Review Focused on SARS-CoV-2, Zika, and Dengue 🤚🏽
An analysis of the antiviral potential of phytochemicals and their applications in the prevention and treatment of SARS-CoV-2, Zika, and dengue.
journals.sagepub.com/doi/10.1177/...
02.10.2025 12:20 — 👍 2 🔁 1 💬 0 📌 0
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
📊 HIV from injection drug use is climbing (2016–2022).
PrEP uptake in PWID remains critically low.
Call to action: integrate ID + addiction care, expand low-barrier services, implement LA-PrEP, and fight stigma through policy + education.
journals.sagepub.com/doi/full/10....
02.10.2025 14:34 — 👍 3 🔁 2 💬 0 📌 0
🚨Call for Papers: @tamedoncol.bsky.social invites submissions on Antibody Drug Conjugates (ADCs) in Gynecologic Cancers. Led by Dr. Angélica Nogueira Rodrigues & Dr. Rowan Miller, this collection spotlights innovative ADC research in gynecologic oncology. 📥 Submit your work. buff.ly/RhdEIHX
03.10.2025 07:15 — 👍 1 🔁 1 💬 0 📌 0
Systematic review & network meta-analysis in advanced EGFR-mutated #NSCLC after TKI failure: chemo+ivonescimab ranked best for PFS with acceptable safety; chemo+amivantamab gave strongest OS/ORR but higher toxicity. Chemo+IO or chemo alone less effective.
journals.sagepub.com/doi/epdf/10....
03.10.2025 14:47 — 👍 1 🔁 1 💬 0 📌 0
Neurobiologist studying the early life origins of obesity and diabetes #DOHaD in the @neuroendolille lab • President, French Society of Neuroendocrinology (SNE) • Views & opinions my own
Cancer epidemiologist. Interests include #NoTobacco #AlcoholAndCancer #LiverCancer #OralCancer #CDoH #PolicyImpact #Rstats #RLadies. Views my own
Associate Professor at Gladstone/UCSF. Studying the mysteries of oxygen and vitamins.
Ph.D. | Postdoc@Shamsi Lab, NYU | Glycobiology | Synthetic Biology
PostDoc @ University of Cambridge, Department of Pathology
Interested in RNA biology and infection
👨🔬 | 🏳️🌈 | he/him
Computational Biologist and Microbiome Scientist at the National University of Singapore
A staff scientist at the National Cancer Center Research Institute, Japan
Ailong Ke's lab at Yale MB&B. We are interested in everything about RNA, especially in CRISPR-Cas, genome editing, novel bacterial immunity systems.
NWO Veni Fellow @TUDelft - (Dissociative) Bioorthogonal Chemistry | Bioconjugation | Antibody-Drug Conjugates (ADCs)
IM Resident Physician at Stanford. UChicago ‘24, Harvard‘16. Medical oncology, mRNA modifications, immunology.
the cell is the best #tissueengineer but I try • currently msca postdoc in daniel kelly lab at trinity college dublin • previously columbia & uc berkeley
Prof at TUM, engineers cell-free systems, artificial cells and synthetic compartments
Postdoctoral Fellow at Marioni Lab, Genentech | Aging & bioinformatics
Born in Portugal 🇵🇹 living in California 🐻
Director of Institute for Computational Genomic Medicine at Goethe University Frankfurt https://cgm.uni-frankfurt.de/
Postdoctoral researcher at TU Delft.
Trying to sequence proteins with #nanopore
Assistant Professor. Neurosurgery. Oncology. Immunology. #UCalgary #Canada
Predoctoral Research Assistant at the Llorca lab @cniostopcancer.bsky.social working on mTORC1 signaling and cryo-EM ❄️🔬. Intrigued by the structural mechanisms of protein assemblies involved in endomembrane signaling and trafficking 🧪.
We are an interdisciplinary group of scientists and engineers working to develop lab-on-a-chip devices for high-throughput bioanalysis at the University of Toronto. https://microfluidics.utoronto.ca/
Professor at Greater Bay Area Institute of Precision Medicine, Fudan University | Glycan/Protein/RNA/Mass Spectrometry | https://glycoxielab.org/
Precision medicine through polymathic AI.
https://linktr.ee/cosynetherapeutics
